future health glp 1 The of Health: GLP-1 Agonists and Everyday Wellbeing The Future of GLP-1s

A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults

Recent developments underscore the relevance of GLP-1R agonists in addressing the complex interplay of cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH)

Additionally, GLP-1R agonists reduce visceral hypersensitivity and ameliorate symptoms in patients with irritable bowel syndrome

For example, semaglutide and empagliflozin showed no significant difference in 3-point MACE (HR 1.05

Supergut, a leader in gut-health innovation, announced the launch of three new flavors of its GLP-1 Booster: Blood Orange, Raspberry Lemon and Watermelon Lime.

Recent Findings Emerging evidence suggests that GLP-1R agonists have a role in pediatric obesity treatment